Atlas Trials

Dose Escalation Study to Evaluate the Safety and Immunogenicity of the Cholera Conjugate Vaccine in Healthy Adults

Clinical trial NCT05559983 · COMPLETED

Trial details

NCT number
NCT05559983
Sponsor
International Vaccine Institute
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Cholera Vaccination Reaction
Start date
2022-12-05
Primary completion
2023-09-08
Enrollment
150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.